Cardiometabolism and Venous Diseases

Where do we focus our efforts?

Cardiovascular, metabolic, and venous diseases (CMVD) are a major public health issue. Many patients face not just one disease, but multiple CMVD-related conditions. And even though treatments are available, far too many patients struggle to follow their prescribed treatment plans to the letter.

• Cardiovascular diseases (primarily hypertension, coronary artery disease, heart failure) and elevated cholesterol levels are on the rise worldwide. To address this public health challenge, we have worked alongside patients and health care professionals on a daily basis for over 70 years.

• Type 2 diabetes accounts for more than 95% of all diabetes cases worldwide³. It is a complex and progressive disease that constitutes a serious public health burden. We have spearheaded a number of global initiatives aimed at improving patient care and quality of life.
• Chronic venous disease and hemorrhoidal disease affect a large number of people and manifest in different ways. And yet, these conditions have a common underlying cause: weakened vein walls and valves, combined with inflammation, which leads to venous insufficiency. For this reason, it is important to treat conditions as soon as symptoms appear and slow their progression toward more advanced stages and/or recurrence. Our work is focused on gaining a better understanding of venous insufficiency and treating related symptoms.